Lack of serological evidence for an association between simian virus 40 and lymphoma
β Scribed by Silvia de Sanjose; Keerti V. Shah; Eva Domingo-Domenech; Eric A. Engels; Alberto Fernandez de Sevilla; Tomas Alvaro; Mercedes Garcia-Villanueva; Vicens Romagosa; Eva Gonzalez-Barca; Raphael P. Viscidi
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- French
- Weight
- 66 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Recent studies have implicated simian virus 40 (SV40) in nonβHodgkin's lymphomas based on detection of SV40 DNA sequences. We employed a virusβlikeβparticle (VLP)βbased enzyme immunoassay for antibodies to SV40 to test sera from 520 lymphoma cases and 587 controls in Spain. The SV40 seroprevalence was 9.5% in controls and 5.9% in cases. Antibody levels of the positive sera were low. There was no association of SV40 seropositivity with any subtype of lymphoma. VLPs of the human BK virus substantially inhibited the SV40 reactivity of human sera. There was no serological evidence of widespread SV40 infection and no association of SV40 seropositivity with human lymphomas in Spain. Β© 2003 WileyβLiss, Inc.
π SIMILAR VOLUMES
Epidemiological evidence suggests that airway obstruction is an independent risk factor for lung cancer and that this cannot be explained by active or passive smoking alone. Chlamydia pneumoniae infection has been associated with chronic bronchitis and its exacerbates. Our aim was to evaluate the as
## Abstract Persons with acquired immunodeficiency syndrome (AIDS) have increased risk for nonβHodgkin's lymphoma (NHL). Recent studies have reported the detection of DNA sequences from simian virus 40 (SV40), a macaque polyomavirus that contaminated early poliovirus vaccines, in a large proportion